Cargando…
Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis
Neutrophils are known to be targets for the biological activity of tumour necrosis factor (TNF)-α in the pathogenensis of rheumatoid arthritis (RA). Therefore, these cells may be among the targets of anti-TNF-α therapy. In this study we evaluated the effect of therapy with adalimumab (a fully human...
Autores principales: | Capsoni, Franco, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Minonzio, Francesca, Bonara, Paola, Doria, Andrea, Carrabba, Mario |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1065317/ https://www.ncbi.nlm.nih.gov/pubmed/15743471 http://dx.doi.org/10.1186/ar1477 |
Ejemplares similares
-
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study
por: Atzeni, Fabiola, et al.
Publicado: (2006) -
Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
por: Benucci, Maurizio, et al.
Publicado: (2013) -
The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses
por: Talotta, Rossella, et al.
Publicado: (2017) -
Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature
por: Benucci, Maurizio, et al.
Publicado: (2011) -
Correlation of the score for subjective pain with physical disability, clinical and radiographic scores in recent onset rheumatoid arthritis
por: Sarzi-Puttini, Piercarlo, et al.
Publicado: (2002)